Article Text

Download PDFPDF

514 Development of AIM-104, a potential best-in-class pan-allele anti-SIRPα antibody for anti-tumor therapy

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.